The Diagnostic Performance of Minimally Invasive Biopsy in Predicting Breast Pathological Complete Response After Neoadjuvant Systemic Therapy in Breast Cancer: A Meta-Analysis

Background: Neoadjuvant systemic therapy (NST) is commonly used in patients with early stage breast cancer before definitive surgery. The standard diagnostic approach for pathologic complete response (pCR) of the breast is breast surgery and pathologic examination. In recent years, several trials in...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Zhou, Yidong, Mao, Feng, Lin, Yan, Zhang, Xiaohui, Shen, Songjie, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333530/
https://www.ncbi.nlm.nih.gov/pubmed/32676452
http://dx.doi.org/10.3389/fonc.2020.00933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333530/
https://www.ncbi.nlm.nih.gov/pubmed/32676452
http://dx.doi.org/10.3389/fonc.2020.00933

Ejemplares similares